Jump to main navigation | Jump to sub navigation | Jump to SiteMap | Jump to Home Page |

Follow us on Twitter

Latest News Releases

News and features

Epistem announces agency agreement with Veritas Japan

Epistem plc announced today that its Contract Research Services division has entered into an agreement with the Veritas Corporation to exclusively market and distribute Epistem's scientific research services in Japan.

2/9/2010

Epistem's Biomarker Division gains GCLP accreditation

Epistem plc has announced today that their Biomarker Division has been awarded Good Clinical Laboratory Practice (GCLP) accreditation status.  

7/6/2010

Epistem to launch RNA-Amp™ kits, for sensitive gene expression analysis, at AACR meeting

Epistem will launch their RNA-Amp kits for mRNA expression amplification, at the American Association for Cancer Research Annual Meeting in Washington DC from April 18-21 2010.

16/4/2010

Epistem to present human plucked hair labelling platform at AACR meeting in Washington DC

Epistem plc will present details of their new plucked hair immunohistochemistry platform at the American Association for Cancer Research Annual Meeting in Washington DC on Tuesday 20th April.  

14/4/2010

Aeolus Pharmaceuticals Inc. initiates second study of lead drug AEOL 10150, conducted by Epistem

Aeolus Pharmaceuticals, Inc. announced today that a second study of its lead drug, AEOL 10150, has been initiated by the National Institutes of Health’s (NIH), National Institute of Allergy and Infectious Diseases (NIAID) Radiation/Nuclear Medical Countermeasures development program as a countermeasure for radiation exposure to the gastrointestinal (GI) tract.

12/4/2010